TRANSACTIONS - CEC CAPITAL

Cancel

Date：2016-11
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=203
Coyote Bioscience, a leading molecular diagnosis company in China, announced today that it had completed Series B financing. The round was led by Northern Light Ventures, with participation from SAIF Asia and Legend Star.
Cancel

Date：2016-02
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=200
Righton Biology, a specialized molecular diagnostics company with test kits for leukemia, lymphoma, and solid tumors, today announced that it had completed its Series A financing.
Cancel

Date：2016-01

-
Cancel

Date：2016-01
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=199
Xingshulin, a leading mobile app focused on providing data and management tools to physicians across the country, announced today that it had completed Series C financing.
Cancel

Date：2015-11
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=205
ET Healthcare, an advanced in-vitro diagnostic technology company, announced today that it had completed a new round of financing, led by Qiming Venture Partners and Masion Capital with participation from the compan's existing shareholders Legend Capital
Cancel

Date：2015-08
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=211
Sino-Kor Plastics Surgery Hospital (NEEQ: 430335), China's largest clinic and hospital chain in plastic surgery listed on China's New Third Board, announced today that it had completed a secondary offering to finance expansion of new hospitals and clinics
Cancel

Date：2015-06
http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=212
Xingren Doctor, a leading mobile platform for doctors in China, announced today that it had raised RMB 200 million in one of the largest Series B rounds in the mobile healthcare space.
Cancel

Date：2015-03

CEC Capital Served as Exclusive Financial Advisor
Cancel

Date：2015-01

-